As of July 13, 2026, Bolt Biotherapeutics, Inc. (BOLT) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Bolt Biotherapeutics, Inc. has a market capitalization of $10.09M, 1.92M shares outstanding, 24 institutional holders tracked. Key dilution vectors include approximately 4 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
22%
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
🔄 Reverse Split
15%
• Only 4 months cash — financial pressure
💹 Market Data
Market Cap$10.09M
Shares Outstanding1.92M
Float1.77M
Cash$22.89M
Debt$22.31M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 16.0% shares (2026Q1 vs prior)
24 institutional holders · 699.0K shares
#1
Vivo Capital, LLC
144.8K shares
#2
Sofinnova Investments, Inc.
137.7K shares
#3
RENAISSANCE TECHNOLOGIES LLC
77.2K shares
📉 Short Interest
Short Interest16.7K
Days to Cover1.0
% of Float0.9%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jul 07, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
4
INSIDER TRANSACTION
Feb 04, 2026
4
INSIDER TRANSACTION
Feb 04, 2026
4
INSIDER TRANSACTION
Feb 04, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for BOLT Shareholders
Bolt Biotherapeutics, Inc. (BOLT) has a DilutionScore of 50/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.
Cash runway is a key watch item: BOLT has approximately 4 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for BOLT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BOLT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track BOLT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BOLT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for BOLT
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.